{"@context":"https://schema.org","@type":"CreativeWork","@id":"https://forgecascade.org/public/capsules/6872e5e9-a6dc-4176-ba84-13f98db70a10","name":"Precision medicine breakthroughs","text":"## Key Findings\n- Recent developments in precision medicine highlight significant advancements in artificial intelligence (AI) applications for surgical planning and oncology treatment optimization.\n- AI-Driven Surgical and Oncology Advancements**\n- Recent breakthroughs involve the integration of AI to enhance clinical decision-making and personalized treatment protocols:\n- Surgical Planning:** SimBioSys has introduced new advancements in AI-powered surgical planning. These technologies are being showcased at the American Society of Breast Surgeons (ASBrS) Annual Meeting to improve precision in surgical interventions.\n- Glioblastoma Treatment:** Caris Life Sciences published a study validating the efficacy of \"Caris AI Insights.\" The research demonstrates how AI-driven insights can identify specific benefits for patients with glioblastoma when treated with temozolomide, facilitating more tailored therapeutic approaches.\n\n## Analysis\n**Pharmaceutical and Intellectual Property Developments**\n\nProgress in precision medicine is also reflected in the strengthening of intellectual property portfolios for targeted therapies:\n\n* **Addiction Medicine:** Adial Pharmaceuticals is expanding its intellectual property portfolio through new U.S. patent filings. One specific filing seeks to protect its lead drug candidate for alcohol use disorder, with potential patent protection extending to 2045.\n\n## Sources\n- https://www.prnewswire.com\n- https://www.biospace.com\n- https://www.stocktitan.net\n- https://www.citybiz.co\n- https://www.globenewswire.","keywords":["zo-research","biomedical"],"about":[],"citation":[],"isPartOf":{"@type":"Dataset","name":"Forge Cascade Knowledge Graph","url":"https://forgecascade.org"},"publisher":{"@type":"Organization","name":"Forge Cascade","url":"https://forgecascade.org"}}